These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10570250)

  • 21. High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).
    Cha SS; Lee D; Adams J; Kurdyla JT; Jones CS; Marshall LA; Bolognese B; Abdel-Meguid SS; Oh BH
    J Med Chem; 1996 Sep; 39(20):3878-81. PubMed ID: 8831753
    [No Abstract]   [Full Text] [Related]  

  • 22. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regioselective synthesis of 4- and 7-alkoxyindoles from 2,3-dihalophenols: application to the preparation of indole inhibitors of phospholipase A2.
    Sanz R; Castroviejo MP; Guilarte V; Pérez A; Fañanás FJ
    J Org Chem; 2007 Jul; 72(14):5113-8. PubMed ID: 17559277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure.
    Abraham E; Naum C; Bandi V; Gervich D; Lowry SF; Wunderink R; Schein RM; Macias W; Skerjanec S; Dmitrienko A; Farid N; Forgue ST; Jiang F
    Crit Care Med; 2003 Mar; 31(3):718-28. PubMed ID: 12626975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asp49 phospholipase A(2)-elaidoylamide complex: a new mode of inhibition.
    Georgieva DN; Rypniewski W; Gabdoulkhakov A; Genov N; Betzel C
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1314-21. PubMed ID: 15194511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbocyclic[g]indole inhibitors of human nonpancreatic s-PLA2.
    Sawyer JS; Beight DW; Smith EC; Snyder DW; Chastain MK; Tielking RL; Hartley LW; Carlson DG
    J Med Chem; 2005 Feb; 48(3):893-6. PubMed ID: 15689175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of specific peptide inhibitors for group I phospholipase A2: structure of a complex formed between phospholipase A2 from Naja naja sagittifera (group I) and a designed peptide inhibitor Val-Ala-Phe-Arg-Ser (VAFRS) at 1.9 A resolution reveals unique features.
    Singh RK; Vikram P; Makker J; Jabeen T; Sharma S; Dey S; Kaur P; Srinivasan A; Singh TP
    Biochemistry; 2003 Oct; 42(40):11701-6. PubMed ID: 14529280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel delta2-isoxazolines as group II phospholipase A2 inhibitors.
    Basappa ; Satish Kumar M; Nanjunda Swamy S; Mahendra M; Shashidhara Prasad J; Viswanath BS; Rangappa KS
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3679-81. PubMed ID: 15203142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of benzophenone oxime analogues as inhibitor of secretory phospholipase A(2) with anti-inflammatory activity.
    Murari SK; Sriharsha SN; Shashikanth S; Vishwanath BS
    Bioorg Med Chem Lett; 2004 May; 14(10):2423-5. PubMed ID: 15109625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding to PLA2 may contribute to the anti-inflammatory activity of catechol.
    Dileep KV; Tintu I; Mandal PK; Karthe P; Haridas M; Sadasivan C
    Chem Biol Drug Des; 2012 Jan; 79(1):143-7. PubMed ID: 21995306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug or tool, design or serendipity?
    Verlinde CL; Dijkstra BW
    Nat Struct Biol; 1995 Jun; 2(6):429-32. PubMed ID: 7664101
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
    Sadashiva MP; Nataraju A; Mallesha H; Rajesh R; Vishwanath BS; Rangappa KS
    Int J Mol Med; 2005 Nov; 16(5):895-904. PubMed ID: 16211261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of phospholipase A(2) as a therapeutic target.
    Yedgar S; Lichtenberg D; Schnitzer E
    Biochim Biophys Acta; 2000 Oct; 1488(1-2):182-7. PubMed ID: 11080687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity.
    Jameel NM; Shekhar MA; Vishwanath BS
    Life Sci; 2006 Dec; 80(2):146-53. PubMed ID: 17011589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes.
    Khanum SA; Murari SK; Vishwanth BS; Shashikanth S
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4100-4. PubMed ID: 15993585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A(2) inhibitors.
    Bernard P; Scior T; Didier B; Hibert M; Berthon JY
    Phytochemistry; 2001 Nov; 58(6):865-74. PubMed ID: 11684183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cytosolic phospholipase A2alpha: hit to lead optimization.
    McKew JC; Foley MA; Thakker P; Behnke ML; Lovering FE; Sum FW; Tam S; Wu K; Shen MW; Zhang W; Gonzalez M; Liu S; Mahadevan A; Sard H; Khor SP; Clark JD
    J Med Chem; 2006 Jan; 49(1):135-58. PubMed ID: 16392799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme.
    Dong CZ; Ahamada-Himidi A; Plocki S; Aoun D; Touaibia M; Meddad-Bel Habich N; Huet J; Redeuilh C; Ombetta JE; Godfroid JJ; Massicot F; Heymans F
    Bioorg Med Chem; 2005 Mar; 13(6):1989-2007. PubMed ID: 15727853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
    De Rosa M; Giordano S; Scettri A; Sodano G; Soriente A; Pastor PG; Alcaraz MJ; Payá M
    J Med Chem; 1998 Aug; 41(17):3232-8. PubMed ID: 9703468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Review of Bisindolylmethane as an Important Scaffold for Drug Discovery.
    Imran S; Taha M; Ismail NH
    Curr Med Chem; 2015; 22(38):4412-33. PubMed ID: 26438249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.